My Quote Request
No products added yet
6505-01-174-4069
20 Products
NDC00053-1219-33
MULTIVITAMIN SOLUTION FOR INJECTION
NSN, MFG P/N
6505011744069
NSN
6505-01-174-4069
NDC00053-1219-33
MULTIVITAMIN SOLUTION FOR INJECTION
NSN, MFG P/N
6505011744069
NSN
6505-01-174-4069
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 25.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 25.000 MICROGRAMS ERGOCALCIFEROL ACTIVE INGREDIENT AND 100.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS PYRIDOXINE
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: TO BE DILUTED WITH NOT LESS THAN 500 ML INFUSION FLUID
~1: HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 50.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT AND 3.000 MILLIGRAMS VITAMIN A ACTIVE INGREDIENT AND 5.000 MILLIGRAMS VITAMIN E ACTIVE INGREDIENT
Related Searches:
01-7013
SULFASALAZINE TABLETS,USP
NSN, MFG P/N
6505011744988
NSN
6505-01-174-4988
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00032-2060-10
SULFASALAZINE TABLETS,USP
NSN, MFG P/N
6505011744988
NSN
6505-01-174-4988
NDC00032-2060-10
SULFASALAZINE TABLETS,USP
NSN, MFG P/N
6505011744988
NSN
6505-01-174-4988
MFG
SOLVAY PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1016-10
SULFASALAZINE TABLETS,USP
NSN, MFG P/N
6505011744988
NSN
6505-01-174-4988
NDC00182-1016-10
SULFASALAZINE TABLETS,USP
NSN, MFG P/N
6505011744988
NSN
6505-01-174-4988
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00223-1727-02
SULFASALAZINE TABLETS,USP
NSN, MFG P/N
6505011744988
NSN
6505-01-174-4988
NDC00223-1727-02
SULFASALAZINE TABLETS,USP
NSN, MFG P/N
6505011744988
NSN
6505-01-174-4988
MFG
CONSOLIDATED MIDLAND CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ALBUMINAR-5
ALBUMIN HUMAN,USP
NSN, MFG P/N
6505011744990
NSN
6505-01-174-4990
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
SPECIAL FEATURES: FOR USE WITH AN INTRAVENOUS ADMINISTRATION SET (INCLUDED);5.0000 PERCENT PER 100 MILLILITERS
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00053-7670-03
ALBUMIN HUMAN,USP
NSN, MFG P/N
6505011744990
NSN
6505-01-174-4990
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
SPECIAL FEATURES: FOR USE WITH AN INTRAVENOUS ADMINISTRATION SET (INCLUDED);5.0000 PERCENT PER 100 MILLILITERS
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
BSS PLUS
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505011745842
NSN
6505-01-174-5842
BSS PLUS
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505011745842
NSN
6505-01-174-5842
MFG
ALCON LABORATORIES INC .
Description
ADMINISTRATION: OPHTHALMIC IRRIGATION
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OPHTHALMIC IRRIGATING SOLUTION 500ML BOTTLE 6S
III THERAPEUTIC EQUIVALENT: BSS PLUS BY ALCON
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS OR 515.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR INTRAOCULAR USE; SHALL CONSIST OF TWO PARTS (PART I AND PART II), SUCH THAT WHEN MIXED TOGETHER, EACH ML OF THE RECONSTITUTED PRODUCT CONTAINS 7.14 MG SODIUM CHLORIDE, 0.38 MG POTASSIUM CHLORIDE, 0.154 MG CALCIUM CHLORIDE DIHYDRATE, 0.42 MGDIBASIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: SODIUM PHOSPHATE (ANHYDROUS), 0.20 MG MAGNESIUM CHLORIDE HEXAHYDRATE, 2.1 MG SODIUM BICARBONATE, 0.92 MG DEXTROSE, 0.184 MG GLUTATHIONE DISULFIDE (OXIDIZED GLUTATHIONE), HYDROCHLORIC ACID AND/OR SODIUM HYDROXIDE (TO ADJUST PH), IN WATER FOR INJECTION; THE
~2: RECONSTITUTED PRODUCT HAS APPROXIMATE PH OF 7.4 AND OSMOLARITY OF APPOXIMATELEY 305 MOSMOL PER LITER; THE UNIT OF ISSUE SHALL BE EITHER SIX 500 ML BTS CONTAINING PART I WITH SIX 20 ML BTS CONTAINING PART II CONCENTRATE OR SIX 515 ML BTS CONTAINING PART I
~3: WITH SIX VIALS CONTAINING LYOPILIZED POWDER FOR PART II, TOGETHER WITH SIX STERILE TRANSFER SPIKES
Related Searches:
NDC00023-0005-51
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505011745842
NSN
6505-01-174-5842
NDC00023-0005-51
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505011745842
NSN
6505-01-174-5842
MFG
ALLERGAN INC
Description
ADMINISTRATION: OPHTHALMIC IRRIGATION
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OPHTHALMIC IRRIGATING SOLUTION 500ML BOTTLE 6S
III THERAPEUTIC EQUIVALENT: BSS PLUS BY ALCON
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS OR 515.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR INTRAOCULAR USE; SHALL CONSIST OF TWO PARTS (PART I AND PART II), SUCH THAT WHEN MIXED TOGETHER, EACH ML OF THE RECONSTITUTED PRODUCT CONTAINS 7.14 MG SODIUM CHLORIDE, 0.38 MG POTASSIUM CHLORIDE, 0.154 MG CALCIUM CHLORIDE DIHYDRATE, 0.42 MGDIBASIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: SODIUM PHOSPHATE (ANHYDROUS), 0.20 MG MAGNESIUM CHLORIDE HEXAHYDRATE, 2.1 MG SODIUM BICARBONATE, 0.92 MG DEXTROSE, 0.184 MG GLUTATHIONE DISULFIDE (OXIDIZED GLUTATHIONE), HYDROCHLORIC ACID AND/OR SODIUM HYDROXIDE (TO ADJUST PH), IN WATER FOR INJECTION; THE
~2: RECONSTITUTED PRODUCT HAS APPROXIMATE PH OF 7.4 AND OSMOLARITY OF APPOXIMATELEY 305 MOSMOL PER LITER; THE UNIT OF ISSUE SHALL BE EITHER SIX 500 ML BTS CONTAINING PART I WITH SIX 20 ML BTS CONTAINING PART II CONCENTRATE OR SIX 515 ML BTS CONTAINING PART I
~3: WITH SIX VIALS CONTAINING LYOPILIZED POWDER FOR PART II, TOGETHER WITH SIX STERILE TRANSFER SPIKES
Related Searches:
NDC00065-0800-50
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505011745842
NSN
6505-01-174-5842
NDC00065-0800-50
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505011745842
NSN
6505-01-174-5842
MFG
ALCON LABORATORIES INC .
Description
ADMINISTRATION: OPHTHALMIC IRRIGATION
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OPHTHALMIC IRRIGATING SOLUTION 500ML BOTTLE 6S
III THERAPEUTIC EQUIVALENT: BSS PLUS BY ALCON
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS OR 515.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR INTRAOCULAR USE; SHALL CONSIST OF TWO PARTS (PART I AND PART II), SUCH THAT WHEN MIXED TOGETHER, EACH ML OF THE RECONSTITUTED PRODUCT CONTAINS 7.14 MG SODIUM CHLORIDE, 0.38 MG POTASSIUM CHLORIDE, 0.154 MG CALCIUM CHLORIDE DIHYDRATE, 0.42 MGDIBASIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: SODIUM PHOSPHATE (ANHYDROUS), 0.20 MG MAGNESIUM CHLORIDE HEXAHYDRATE, 2.1 MG SODIUM BICARBONATE, 0.92 MG DEXTROSE, 0.184 MG GLUTATHIONE DISULFIDE (OXIDIZED GLUTATHIONE), HYDROCHLORIC ACID AND/OR SODIUM HYDROXIDE (TO ADJUST PH), IN WATER FOR INJECTION; THE
~2: RECONSTITUTED PRODUCT HAS APPROXIMATE PH OF 7.4 AND OSMOLARITY OF APPOXIMATELEY 305 MOSMOL PER LITER; THE UNIT OF ISSUE SHALL BE EITHER SIX 500 ML BTS CONTAINING PART I WITH SIX 20 ML BTS CONTAINING PART II CONCENTRATE OR SIX 515 ML BTS CONTAINING PART I
~3: WITH SIX VIALS CONTAINING LYOPILIZED POWDER FOR PART II, TOGETHER WITH SIX STERILE TRANSFER SPIKES
Related Searches:
NDC00039-0019-11
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505011749915
NSN
6505-01-174-9915
NDC00039-0019-11
CEFOTAXIME SODIUM,USP
NSN, MFG P/N
6505011749915
NSN
6505-01-174-9915
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFOTAXIME EQUIVALENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOTAXIME SODIUM STERILE USP 2GM BOTTLE 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: IN AN OVERSIZED BT W/A RATED CAPACITY OF NOT LESS THAN 100ML
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
FP-R-3 SINGLE KIT
ANTIDOTE TREATMENT KIT,NERVE AGENT
NSN, MFG P/N
6505011749919
NSN
6505-01-174-9919
FP-R-3 SINGLE KIT
ANTIDOTE TREATMENT KIT,NERVE AGENT
NSN, MFG P/N
6505011749919
NSN
6505-01-174-9919
MFG
MERIDIAN MEDICAL TECHNOLOGIES INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIDOTE TREATMENT KIT NERVE AGENT
SPECIAL FEATURES: EITHER INJECTOR SHALL BE ARMED AND READY FOR ADMINISTRATION WHEN REMOVED FROM THE HOLDER; KIT COMPONENTS SHALL BE REPLACEABLE
TEST CAPABILITY QUANTITY: 1
USAGE DESIGN: FOR USE AS AN ANTIDOTE FOR NERVE GAS
Related Searches:
MARK I
ANTIDOTE TREATMENT KIT,NERVE AGENT
NSN, MFG P/N
6505011749919
NSN
6505-01-174-9919
MARK I
ANTIDOTE TREATMENT KIT,NERVE AGENT
NSN, MFG P/N
6505011749919
NSN
6505-01-174-9919
MFG
MERIDIAN MEDICAL TECHNOLOGIES INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIDOTE TREATMENT KIT NERVE AGENT
SPECIAL FEATURES: EITHER INJECTOR SHALL BE ARMED AND READY FOR ADMINISTRATION WHEN REMOVED FROM THE HOLDER; KIT COMPONENTS SHALL BE REPLACEABLE
TEST CAPABILITY QUANTITY: 1
USAGE DESIGN: FOR USE AS AN ANTIDOTE FOR NERVE GAS
Related Searches:
P0125
POLYETHYLENE GLYCOL,NF
NSN, MFG P/N
6505011749926
NSN
6505-01-174-9926
MFG
SPECTRUM LABORATORY PRODUCTS INC. DBA SPECTRUM CHEMICALS AND LABORATORY PRODUCTS
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYETHYLENE GLYCOL NF POWDER FORM 1LB JAR
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 POUNDS
PRIMARY CONTAINER TYPE: JAR, GLASS
Related Searches:
NDC00068-0104-61
PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011749930
NSN
6505-01-174-9930
NDC00068-0104-61
PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011749930
NSN
6505-01-174-9930
MFG
MERRELL DOW PHARMECEUTICALS INC BIDS AND CONTRACTS DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS PSEUDOEPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SHALL PROVIDE CONTINUOUS THERAPEUTIC EFFECT FOR 12 HOURS
Related Searches:
NOVAFED
PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011749930
NSN
6505-01-174-9930
NOVAFED
PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505011749930
NSN
6505-01-174-9930
MFG
MERRELL DOW PHARMECEUTICALS INC BIDS AND CONTRACTS DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS PSEUDOEPHEDRINE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SHALL PROVIDE CONTINUOUS THERAPEUTIC EFFECT FOR 12 HOURS
Related Searches:
NDC00168-0020-31
HYDROCORTISONE OINTMENT,USP
NSN, MFG P/N
6505011749931
NSN
6505-01-174-9931
NDC00168-0020-31
HYDROCORTISONE OINTMENT,USP
NSN, MFG P/N
6505011749931
NSN
6505-01-174-9931
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ACTIVE INGREDIENT AND STRENGTH: 1.000 HYDROCORTISONE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROCORTISONE OINTMENT 1% TOPICAL 1OZ TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
NDC00143-9979-22
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505011751228
NSN
6505-01-175-1228
NDC00143-9979-22
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505011751228
NSN
6505-01-175-1228
MFG
WEST-WARD PHARMACEUTICAL CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 750MG VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 750.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC10019-0620-01
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505011751228
NSN
6505-01-175-1228
NDC10019-0620-01
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505011751228
NSN
6505-01-175-1228
MFG
BAXTER HEALTHCARE CORP SCIENTIFIC TECHNICAL SYSTEMS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 750MG VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 750.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
ZINACEF
CEFUROXIME SODIUM,USP
NSN, MFG P/N
6505011751228
NSN
6505-01-175-1228
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CEFUROXIME EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFUROXIME SODIUM STERILE 750MG VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 750.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
